Frisina N - Search Results

1

Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia.

Buemi M, Allegra A, Anastasi G, Aloisi C, Montalto G, Frisina N. Buemi M, et al. Among authors: frisina n. Clin Nephrol. 1997 Feb;47(2):134-5. Clin Nephrol. 1997. PMID: 9049467 No abstract available.

2

The circadian rhythm of erythropoietin in subjects with pre-terminal uremia.

Buemi M, Allegra A, Aloisi C, Mannino G, Trusso S, Vitulo F, Privitera M, Morabito N, Frisina N. Buemi M, et al. Among authors: frisina n. Clin Nephrol. 1992 Mar;37(3):159-60. Clin Nephrol. 1992. PMID: 1563123 No abstract available.

3

Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed subjects.

Buemi M, Allegra A, Aloisi C, Frisina N. Buemi M, et al. Among authors: frisina n. Am J Nephrol. 1991;11(4):281-3. doi: 10.1159/000168322. Am J Nephrol. 1991. PMID: 1799185

4

Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.

Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N. Buemi M, et al. Among authors: frisina n. J Nephrol. 2002 Mar-Apr;15(2):97-103. J Nephrol. 2002. PMID: 12018644 Review.

5

Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients.

Buemi M, Allegra A, Aloisi C, Giacobbe MS, Frisina N. Buemi M, et al. Among authors: frisina n. Nephron. 1990;56(2):218-9. doi: 10.1159/000186137. Nephron. 1990. PMID: 2243581 Free article. No abstract available.

6

[Erythropoietin: current aspects and prospects].

Allegra A, Buemi M, Corica F, Giacobbe MS, Frisina N, Ceruso D. Allegra A, et al. Among authors: frisina n. Recenti Prog Med. 1989 Oct;80(10):531-6. Recenti Prog Med. 1989. PMID: 2690220 Review. Italian.

7

Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.

Buemi M, Allegra A, Laganà A, Aloisi C, Privitera M, Morabito N, Frisina N. Buemi M, et al. Among authors: frisina n. Riv Eur Sci Med Farmacol. 1993 Sep-Dec;15(5-6):195-7. Riv Eur Sci Med Farmacol. 1993. PMID: 7761669 Clinical Trial.

8

Influence of the treatment with recombinant human erythropoietin on plasma concentration of interleukin-1-alpha and tumour necrosis factor-alpha in hemodialyzed subjects.

Buemi M, Allegra A, Aloisi C, Privitera M, Morabito N, Frisina N. Buemi M, et al. Among authors: frisina n. Nephron. 1993;64(2):333-4. doi: 10.1159/000187347. Nephron. 1993. PMID: 8321378 Free article. No abstract available.

9

[Rapid, progressive deterioration of renal function following erroneous administration of high doses of subcutaneous recombinant erythropoietin].

Buemi M, Allegra A, Aloisi C, Corica F, Frisina N. Buemi M, et al. Among authors: frisina n. Riv Eur Sci Med Farmacol. 1996 Jan-Feb;18(1):39-42. Riv Eur Sci Med Farmacol. 1996. PMID: 8766781 Italian.

10

Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits?

Buemi M, Allegra A, Corica F, Calapai G, Cavallaro G, Aloisi C, Pettinato G, Russo A, Frisina N. Buemi M, et al. Among authors: frisina n. Nephrol Dial Transplant. 1998 Oct;13(10):2706-8. doi: 10.1093/ndt/13.10.2706b. Nephrol Dial Transplant. 1998. PMID: 9794599 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters